Elawyers Elawyers
Washington| Change

IDENIX PHARMACEUTICALS LLC v. GILEAD PHARMASSET LLC, 15-416-LPS-CJB. (2016)

Court: District Court, D. Delaware Number: infdco20161117e31 Visitors: 1
Filed: Nov. 16, 2016
Latest Update: Nov. 16, 2016
Summary: MEMORANDUM ORDER LEONARD P. STARK , District Judge . WHEREAS, United States Magistrate Judge Christopher J. Burke issued a six-page Report and Recommendation ("R&R") (D.I. 23), dated July 5, 2016, recommending that Defendant's motion to dismiss for lack of subject matter jurisdiction, pursuant to Federal Rule of Civil Procedure 12(b)(1) (D.I. 9) be granted; WHEREAS, on July 22, 2016, Plaintiffs filed their objections to the R&R (D.I. 24); WHEREAS, on August 8, 2016, Defendant responded t
More

MEMORANDUM ORDER

WHEREAS, United States Magistrate Judge Christopher J. Burke issued a six-page Report and Recommendation ("R&R") (D.I. 23), dated July 5, 2016, recommending that Defendant's motion to dismiss for lack of subject matter jurisdiction, pursuant to Federal Rule of Civil Procedure 12(b)(1) (D.I. 9) be granted;

WHEREAS, on July 22, 2016, Plaintiffs filed their objections to the R&R (D.I. 24);

WHEREAS, on August 8, 2016, Defendant responded to Plaintiffs' objections (D.I. 25);

WHEREAS, the Court has considered the motion de novo, see Masimo Corp. v. Philips

Elec. N Am. Corp., 62 F.Supp.3d 368, 379 (D. Del. 2014); 28 U.S.C. § 636(b)(1); Fed. R. Civ. P. ("Rule(s)") 72(b)(3), and has further reviewed all of the pertinent filings;

NOW THEREFORE, IT IS HEREBY ORDERED that:

1. Plaintiffs' objections (D.I. 24) are OVERRULED. Judge Burke's R&R (D.I. 23) is ADOPTED in full. Defendant's motion (D.I. 9) is GRANTED and the case is DISMISSED.

2. The Court is bound by the Federal Circuit's precedential opinion in Biogen MA, Inc. v. Japanese Foundation for Cancer Research, 785 F.3d 648 (Fed. Cir. 2015), which held that district courts lack subject matter jurisdiction, pursuant to 35 U.S.C. § 146, over challenges to the result of a PTO interference that was declared after September 15, 2012. The Federal Circuit denied en bane review of its decision in Biogen and the Supreme Court denied a petition for a writ of certiorari. See 136 S.Ct. 1450 (2016). As this case involves a challenge to the result of a PTO interference that was declared after September 15, 2012, the Court lacks jurisdiction to resolve the parties' dispute

3. The Court is not persuaded that it should exercise its discretion to stay this action, hold the motion to dismiss in abeyance, or — instead of dismissing the action — transfer this case to the Federal Circuit, which does have jurisdiction to hear challenges to the result of an interference. See 35 U.S.C. § 141. Plaintiff has pending an appeal in the Federal Circuit from the same interference to which the instant action is directed. See Storer v. Clark, 15-1802 (Fed. Cir.). Plaintiff may, of course, if it wishes now appeal this Court's dismissal of this action.

4. Given the reasoning provided in the R&R, and given that both parties' arguments are fully addressed by the R&R to the extent not addressed here, the Court finds it unnecessary to address Plaintiffs' Objections any further.

Source:  Leagle

Can't find what you're looking for?

Post a free question on our public forum.
Ask a Question
Search for lawyers by practice areas.
Find a Lawyer